{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:04:28Z","timestamp":1790193868582,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000973","name":"Cystic Fibrosis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100025606","name":"Chambers Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","cysticfibrosisjournal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jcf.2024.11.014","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T23:49:49Z","timestamp":1733442589000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Lens-related ocular changes in fetal rats following in-utero exposure to elexacaftor-tezacaftor-ivacaftor"],"prefix":"10.1016","volume":"24","author":[{"given":"Yimin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Habgood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly R","family":"Chinnery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6044-4824","authenticated-orcid":false,"given":"Elena K.","family":"Schneider-Futschik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcf.2024.11.014_bib0001","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcf.2021.07.019","article-title":"Pregnancy in cystic fibrosis: review of the literature and expert recommendations","volume":"21","author":"Jain","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2024.11.014_bib0002","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/acsptsci.0c00098","article-title":"The balance between the safety of mother, fetus, and newborn undergoing cystic fibrosis transmembrane conductance regulator treatments during pregnancy","volume":"3","author":"Qiu","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.jcf.2024.11.014_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116155","article-title":"Fetal drug exposure after maternally administered CFTR modulators elexacaftor\/tezacaftor\/ivacaftor in a rat model","volume":"171","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.jcf.2024.11.014_bib0004","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jcf.2021.06.005","article-title":"Entry of cystic fibrosis transmembrane conductance potentiator ivacaftor into the developing brain and lung","volume":"20","author":"Qiu","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"15","key":"10.1016\/j.jcf.2024.11.014_bib0005","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/bph.16417","article-title":"Extent of foetal exposure to maternal elexacaftor\/tezacaftor\/ivacaftor during pregnancy","volume":"181","author":"Li","year":"2024","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jcf.2024.11.014_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101299","article-title":"The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health","volume":"103","author":"Schneider-Futschik","year":"2024","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jcf.2024.11.014_bib0007","unstructured":"F.D.A. Trikafta (elexacaftor\/tezacaftor\/ivacaftor) Prescribing Information. 2023; Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/217660s000lbl.pdf."},{"key":"10.1016\/j.jcf.2024.11.014_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1265138","article-title":"Ocular development after highly effective modulator treatment early in life","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.jcf.2024.11.014_bib0009","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jcf.2022.10.004","article-title":"Congenital bilateral cataracts in newborns exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breast feeding","volume":"21","author":"Jain","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.jcf.2024.11.014_bib0010","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1167\/iovs.14-15595","article-title":"Monitoring of strain-dependent responsiveness to TLR activation in the mouse anterior segment using SD-OCT","volume":"55","author":"Downie","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"161","key":"10.1016\/j.jcf.2024.11.014_bib0011","doi-asserted-by":"crossref","DOI":"10.3791\/61588-v","article-title":"In vivo structural assessments of ocular disease in rodent models using optical coherence tomography","author":"Allen","year":"2020","journal-title":"J Vis Exp"},{"issue":"5","key":"10.1016\/j.jcf.2024.11.014_bib0012","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/acsptsci.0c00103","article-title":"Multiple reaction monitoring mass spectrometry for the drug monitoring of ivacaftor, tezacaftor, and elexacaftor treatment response in cystic fibrosis: a high-throughput method","volume":"3","author":"Reyes-Ortega","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"4","key":"10.1016\/j.jcf.2024.11.014_bib0013","doi-asserted-by":"crossref","first-page":"C673","DOI":"10.1152\/ajpcell.00384.2001","article-title":"Expression, localization, and functional evaluation of CFTR in bovine corneal endothelial cells","volume":"282","author":"Sun","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"10.1016\/j.jcf.2024.11.014_bib0014","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0420.1996.tb00079.x","article-title":"Ocular axial length in children with unilateral congenital cataract","volume":"74","author":"Kugelberg","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"issue":"2","key":"10.1016\/j.jcf.2024.11.014_bib0015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.survophthal.2021.05.010","article-title":"Meta-analysis of ocular axial length in newborns and infants up to 3 years of age","volume":"67","author":"Groot","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.jcf.2024.11.014_bib0016","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/bjo.72.5.348","article-title":"Lens thickness in early cataract","volume":"72","author":"Perkins","year":"1988","journal-title":"British Journal of Ophthalmology"},{"issue":"6","key":"10.1016\/j.jcf.2024.11.014_bib0017","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/01926233211010444","article-title":"Exacerbation of background nuclear cataracts in sprague-dawley rats in embryo-fetal development studies with JNJ-42165279, a fatty acid amide hydrolase inhibitor","volume":"49","author":"van Heerden","year":"2021","journal-title":"Toxicol Pathol"},{"issue":"Pt 3b","key":"10.1016\/j.jcf.2024.11.014_bib0018","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/eye.1999.117","article-title":"Lens development","volume":"13","author":"McAvoy","year":"1999","journal-title":"Eye (Lond)"},{"issue":"8","key":"10.1016\/j.jcf.2024.11.014_bib0019","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1364\/BOE.9.003821","article-title":"Volumetric macro- and micro-scale assessment of crystalline lens opacities in cataract patients using long-depth-range swept source optical coherence tomography","volume":"9","author":"Grulkowski","year":"2018","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.jcf.2024.11.014_bib0020","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2147\/OPTH.S37393","article-title":"Subluxed traumatic cataract: optical coherence tomography findings and clinical management","volume":"6","author":"Kuriyan","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.jcf.2024.11.014_bib0021","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jcrs.2018.11.009","article-title":"Role of anterior segment optical coherence tomography for safer management of mature white cataracts","volume":"45","author":"Dhami","year":"2019","journal-title":"J Cataract Refract Surg"},{"issue":"10","key":"10.1016\/j.jcf.2024.11.014_bib0022","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/bjo.74.10.631","article-title":"Histology of the lens in the Weill-Marchesani syndrome","volume":"74","author":"Fujiwara","year":"1990","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jcf.2024.11.014_bib0023","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-4835(74)90030-X","article-title":"Morphology of a hereditary cataract in the rat","volume":"19","author":"Gorthy","year":"1974","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jcf.2024.11.014_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(24)00167-X","article-title":"CF Ferrets exposed to in utero ivacaftor do not develop lens abnormalities","author":"Taylor-Cousar","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2024.11.014_bib0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/jop.2019.0087","article-title":"Nanomolar potency aminophenyltriazine cftr activator reverses corneal epithelial injury in a mouse model of dry eye","volume":"36","author":"Chen","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jcf.2024.11.014_bib0026","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcdb.2007.10.003","article-title":"Congenital cataracts and their molecular genetics","volume":"19","author":"Hejtmancik","year":"2008","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.jcf.2024.11.014_bib0027","first-page":"133","article-title":"Electron microscopic study of galactose-induced cataract","volume":"8","author":"KUWABARA","year":"1969","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jcf.2024.11.014_bib0028","doi-asserted-by":"crossref","DOI":"10.1242\/dev.155838","article-title":"Light-focusing human micro-lenses generated from pluripotent stem cells model lens development and drug-induced cataract in vitro","volume":"145","author":"Murphy","year":"2018","journal-title":"Development"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324018514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324018514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:11:55Z","timestamp":1738275115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324018514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1569199324018514"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.11.014","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lens-related ocular changes in fetal rats following in-utero exposure to elexacaftor-tezacaftor-ivacaftor","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}